Results 241 to 250 of about 341,197 (295)

Structural flexibility of the nicotinamide group of NADH in butanol dehydrogenase YqdH from Fusobacterium nucleatum. [PDF]

PLoS One
Bai X, Nam KH, Xu Y.
europepmc   +1 more source

FNR-like unit interacts with C-terminal related residues trigger nNOS reductase domain conformational flexibility change. [PDF]

Front Neurosci
Wang Y, Wang N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cofactor dependent and cofactor independent anticardiolipin antibodies

Thrombosis Research, 1991
Two distinct types of anticardiolipin antibodies are described, one of which requires the presence of a serum factor (cofactor) to bind cardiolipin in ELISA and liposome affinity systems. The second type does not require this cofactor. The requirement of a cofactor for the binding of some but not all anticardiolipin antibodies provides an explanation ...
L W, Chamley, E J, McKay, N S, Pattison
openaire   +2 more sources

Novel cofactor derivatives and cofactor-based models

Current Opinion in Chemical Biology, 1998
In 1997 and the first half of 1998, numerous publications appeared reporting studies of cofactors and their analogues in classical model systems and in enzyme-catalyzed reactions directed at understanding the enzymatic reactions of their natural cofactors. Model systems based on flavins have provided new insights into enzymatic modulation of the flavin
P K, Mishra, D G, Drueckhammer
openaire   +2 more sources

Cofactor Chemogenomics

2009
Cofactors are organic molecules, most of them originating from vitamins, that bind to enzymes making them able to catalyze defined reactions. A cofactor-based chemogenomics approach exploits the presence of a cofactor-binding domain to develop compound scaffolds tailored to mimic the cofactor and to replace it within target enzyme classes. As a result,
SINGH R, MOZZARELLI, Andrea
openaire   +2 more sources

Evaluation of cofactor responsiveness

Journal of Inherited Metabolic Disease, 1985
AbstractThe response to cofactor therapy in inborn errors of metabolism may be dramatic with complete resolution of the clinical illness but more commonly the response is absent or partial. When assessing cofactor responsiveness clinical and biochemical findings as well as the natural history of the disorder must be taken into account.
J V, Leonard, P, Daish
openaire   +2 more sources

An unexpected cofactor

Science, 2019
A mystery of bacterial chromosome segregation is explained by a nucleotide ...
openaire   +2 more sources

Cofactor squelching: Artifact or fact?

BioEssays, 2016
Cofactor squelching is the term used to describe competition between transcription factors (TFs) for a limited amount of cofactors in a cell with the functional consequence that TFs in a given cell interfere with the activity of each other. Since cofactor squelching was proposed based primarily on reporter assays some 30 years ago, it has remained ...
Søren Fisker Schmidt, Bjørk Ditlev Larsen, Anne Loft, Susanne Mandrup   +3 more
openaire   +3 more sources

Molybdenum cofactor deficiency

The Journal of Pediatrics, 1993
We describe a new case of molybdenum cofactor deficiency, an underrecognized inborn error of metabolism that results in neonatal seizures and neurologic abnormalities. Characteristic biochemical defects in affected individuals include hypouricemia, elevated urine sulfate (detectable by dipstick), and elevated S-sulfocysteine (detectable by anion ...
G L, Arnold, C L, Greene, J P, Stout, S I, Goodman   +3 more
openaire   +2 more sources

Cofactor of the “Lupus Anticoagulant”

Thrombosis and Haemostasis, 1974
SummaryNormal plasma contains an activity known as cofactor which further lengthens the clotting time of the plasma of some patients with the “lupus anticoagulant.55 Cofactor has been characterized as either prothrombin or a gamma globulin. Our findings indicate that cofactor has the following properties: stable at room temperature but largely ...
G E, Rivard, S, Schiffman, S I, Rapaport
openaire   +2 more sources